Nikoloz Shkriabai
Immunology and Microbiology · The Ohio State University
Publications
25
Citations
1,248
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2013
This researcher studies how HIV-1 and related viruses (including HTLV-1 and hepatitis C virus) interact with host proteins and how their structural components assemble and function, using techniques like cryo-electron microscopy and biochemical/structural analysis. A major focus is the HIV-1 capsid, including how new antiviral drugs (such as lenacapavir) and host restriction factors (such as MX2) disrupt its structure to block infection. This work is relevant to students interested in virology, structural biology, and antiviral drug mechanisms.
Publication output has been steady at about one paper per year over most of the last decade, with a notable increase to multiple publications in 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- MX2 Mediates Collapse of the HIV-1 Capsid
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Identification of human T lymphotropic virus type-1 p30 protein phosphorylations and computational analysis of their effect on intrinsically disordered nature of p30
Figshare · 2026
- Identification of human T lymphotropic virus type-1 p30 protein phosphorylations and computational analysis of their effect on intrinsically disordered nature of p30
Journal of Biomolecular Structure and Dynamics · 2026
- Identification of human T lymphotropic virus type-1 p30 protein phosphorylations and computational analysis of their effect on intrinsically disordered nature of p30
Figshare · 2026
- The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir
PLoS Pathogens · 2025
- The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Prion-like low complexity regions enable avid virus-host interactions during HIV-1 infection
Nature Communications · 2022
- Structural and mechanistic bases for a potent HIV-1 capsid inhibitor
Science · 2020
- Cryo-EM structures and atomic model of the HIV-1 strand transfer complex intasome
Science · 2017
- Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap
ACS Infectious Diseases · 2016
- Dynamic Interconversions of HCV Helicase Binding Modes on the Nucleic Acid Substrate
ACS Infectious Diseases · 2016
- HIV‐1インテグラーゼはウイルスRNAゲノムを結合し,ビリオン形態形成中に必須である【Powered by NICT】
Cell (Cambridge, Mass.) · 2016
- Science×2
- ACS Infectious Diseases×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Figshare×2
- Cell×1
- Kristine E. Yoder
Immunology and Microbiology · The Ohio State University
- Ajay K. Ghosh
Immunology and Microbiology · Purdue University West Lafayette
- Ekaterina Knyazhanskaya
Immunology and Microbiology · Indiana University
- Amit Sharma
Immunology and Microbiology · The Ohio State University
- Mamuka Kvaratskhelia
Immunology and Microbiology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile